Evidence map›Paper›PMID 36161105›Full record

ArticleJournal of analytical methods in chemistry2022

Simultaneous Determination of 32 Pyrrolizidine Alkaloids in Two Traditional Chinese Medicine Preparations by UPLC-MS/MS.

Shi Cheng, Wei Sun, Xiaoning Zhao, Ping Wang, Wensheng Zhang, Shunnan Zhang, Xiangwei Chang, Zhengliang Ye

Abstract read
In one paragraph

Article in Journal of analytical methods in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shi ChengSchool of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
Wei SunInternational Industry Center, Tasly Pharmaceutical Group Co. Ltd., Tianjin 300410, China.
Xiaoning ZhaoInternational Industry Center, Tasly Pharmaceutical Group Co. Ltd., Tianjin 300410, China.
Ping WangInternational Industry Center, Tasly Pharmaceutical Group Co. Ltd., Tianjin 300410, China.
Wensheng ZhangInternational Industry Center, Tasly Pharmaceutical Group Co. Ltd., Tianjin 300410, China.
Shunnan ZhangInternational Industry Center, Tasly Pharmaceutical Group Co. Ltd., Tianjin 300410, China.
Xiangwei ChangCollege of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.ORCID https://orcid.org/0000-0002-7649-7258
Zhengliang YeInternational Industry Center, Tasly Pharmaceutical Group Co. Ltd., Tianjin 300410, China.ORCID https://orcid.org/0000-0002-6640-9664

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyrrolizidine alkaloids (PAs) constitute a class of phytotoxin which demonstrates strong hepatotoxicity. In China, many plants containing PAs are used as traditional medicines or medicinal preparations, which could harm human health and safety. Xiaoyao Tablet (XYT) is an antidepressant drug registered in the European Union (EU), Compound Danshen Dropping Pills (CDDP) is a commonly used drug for coronary heart disease, and phase III clinical study is ongoing in the United States. The purpose of this study is to provide data to support the use of Chinese medicine preparations internationally and to establish analytical methods for 32 PAs in XYT and CDDP. The extraction parameters that were optimized include solid-phase extraction (SPE) cartridge, extraction method, and extraction solvent. Then ultra-performance liquid chromatography coupled with triple-quadrupole linear ion-traptandem mass spectrometry (UPLC-MS/MS) was developed to effectively and efficiently quantify the 32 PAs of the XYT and CDDP. The analytical methods for XYT and CDDP were verified respectively. For XYT, the analytical method for 32 PAs was linear, and the correlation coefficient

Identifiers

PMID36161105
PMCPMC9492412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.